Download the Article: 'A uniquely English genomic medicine service'

The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.

Please enter your details so we can email you the content:

First Name Last Name Email Company Job Title Sign up for our monthly newsletter. You can unsubscribe at any time. Please see our Privacy Policy for more details. I agree to receive email content from Blue Latitude Network in accordance with the Privacy Policy. You can unsubscribe at any time.

Other articles you may be interested in

Genetic counsellors: the new healthcare influencers?

Blue Latitude Health explores the relationship between physicians and genetic counsellors, and the impact this has on turning precision medicine into a reality for oncology patients.

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy

Battling breast cancer with precision medicine (Part 1)

Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate tells her story and explains what industry needs to remember when treating cancer patients with precision medicine.

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

Sign up for our newsletters to receive...